Hyperglycemia and Hyperlipidemia Act Synergistically to Induce Renal Disease in LDL Receptor-Deficient BALB Mice

American Journal of Nephrology

Volumn 24, Issue 1, 2004, Pages 20-31

  Spencer, Min W ^a   Mühlfeld, Anja S ^a,b   Segerer, Stephan ^c   Hudkins, Kelly L ^a   Kirk, Elizabeth ^a   LeBoeuf, Renée C ^a   Alpers, Charles E ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Apoptosis; BALB.LDLR ; Diabetic nephropathy; Extracellular matrix; Hyperglycemia; Hyperlipidemia; Tubular degeneration

Indexed keywords

LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATION; DIETARY INTAKE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEEDING; FEMALE; GLOMERULUS; HYPERGLYCEMIA; HYPERLIPIDEMIA; KIDNEY CELL; KIDNEY DISEASE; KIDNEY INTERSTITIUM; KIDNEY TUBULE EPITHELIUM; LIPID STORAGE; MALE; MESANGIUM; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RANDOMIZATION; STANDARDIZATION; STREPTOZOCIN DIABETES; TURNOVER TIME; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX; FEMALE; HYPERGLYCEMIA; HYPERLIPIDEMIAS; KIDNEY GLOMERULUS; KIDNEY TUBULES; LIPIDS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, LDL;

EID: 1342280478     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075362     Document Type: Article

References (52)

1. USRDS 2001 Annual Data Report from Renal Data System: Bethesda, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2001.
2. Colhoun HM, Lee ET, Bennett PH, et al: Risk factors for renal failure: The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001;44(suppl 2):S46-53.
3. Krolewski AS, Laffel LM, Krolewski M, et al: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995;332:1251-1255.
4. Joint Working Party on Diabetic Renal Failure of the British Diabetic Association, the Renal Association and the Research Unit of the Royal College of Physicians: Renal Failure in Diabetics in the UK: Deficient provision of care in 1985. Diabetic Med 1988;5:79-84.
5. United States Renal Data Systems: Annual report: Causes of ESRD. Am J Kidney Dis 1990;15:22-27.
6. Torffvit O, Agardh CD: The impact of metabolic and blood pressure control on incidence and progression of nephropathy: A 10-year study of 385 type 2 diabetic patients. J Diab Compl 2001;15:307-313.
7. Harvey JN, Rizvi K, Craney L, et al: Population-based survey and analysis of trends in the prevalence of diabetic nephropathy in type 1 diabetes. Diab Med 2001;18:998-1002.
8. Turner RC, Millns H, Neil HA, et al: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998;316:823-828.
9. Guijarro C, Kasiske BL, Kim Y, et al: Early glomerular changes in rats with dietary-induced hypercholesterolemia. Am J Kidney Dis 1995;26:152-161.
10. Hattori M, Nikolic-Paterson DJ, Miyazaki K, et al: Mechanisms of glomerular macrophage infiltration in lipid-induced renal injury. Kidney Int Suppl 1999;71:S47-50.
11. Joles JA, Kunter U, Janssen U, et al: Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 2000;11:669-683.
12. Kasiske BL, O'Donnell MP, Schmitz PG, et al: Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 1990;37:880-891.
13. Kamanna VS, Kirschenbaum MA: Association between very-low-density lipoprotein and glomerular injury in obese Zucker rats. Am J Nephrol 1993;13:53-58.
14. Wen M, Segerer S, Dantas M et al: Renal injury in apolipoprotein e-deficient mice. Lab Invest 2002;82:999-1006.
15. Mulec H, Johnson SA, Bjorck S: Relation between serum cholesterol and diabetic nephropathy. Lancet 1990;335:1537-1538.
16. Krolewski AS, Warram JH, Christlieb AR: Hypercholesterolemia - a determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int Suppl 1994;45:S125-131.
17. Silveiro SP, Friedman R, Gross JL: Glomerular hyperfiltration in NIDDM patients without overt proteinuria. Diab Care 1993;16:115-119.
18. Ravid M, Brosh D, Ravid-Safran D, et al: Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 1998;158:998-1004.
19. Jerums G, Allen TJ, Tsalamandris C, et al: Relationship of progressively increasing albuminuria to apoprotein(a) and blood pressure in type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetic patients. Diabetologia 1993;36:1037-1044.
20. Yokota C, Kimura G, Inenaga T, et al: Risk factors for progression of diabetic nephropathy. Am J Nephrol 1995;15:488-492.
21. Shoji T, Nishizawa Y, Toyokawa A, et al: Decreased albuminuria by pravastatin in hyperlipidemic diabetics. Nephron 1991;59:664-665.
22. Sasaki T, Kurata H, Nomura K, et al: Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus. Jpn J Med 1990;29:156-163.
23. Tonolo G, Ciccarese M, Brizzi P, et al: Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment. Diab Care 1997;20:1891-1895.
24. Segerer S, Hudkins KL, Taneda S, et al: Oral interferon-alpha treatment of mice with cryoglobulinemic glomerulonephritis. Am J Kidney Dis 2002;39:876-888.
25. Hugo C, Shankland SJ, Bowen-Pope DF, et al: Extraglomerular origin of the mesangial cell after injury: A new role of the juxtaglomerular apparatus. J Clin Invest 1997;100:786-794.
26. Hiromura K, Haseley LA, Zhang P, et al: Podocyte expression of the CDK-inhibitor p57 during development and disease. Kidney Int 2001;60:2235-2246.
27. Segerer S, Eitner F, Cui Y, et al: Cellular injury associated with renal thrombotic microangiopathy in human immunodeficiency virus-infected macaques. J Am Soc Nephrol 2002;13:370-378.
28. Alpers CE, Hudkins KL, Pritzl P, et al: Mechanisms of clearance of immune complexes from peritubular capillaries in the rat. Am J Pathol 1991;139:855-867.
29. Alpers CE, Hudkins KL, Gown AM, et al: Enhanced expression of 'muscle-specific' actin in glomerulonephritis. Kidney Int 1992;41:1134-1142.
30. Smellie WS, Warwick GL: Primary hyperlipidaemia is not associated with increased urinary albumin excretion. Nephrol Dial Transplant 1991;6:398-401.
31. Keane WF: The role of lipids in renal disease: Future challenges. Kidney Int Suppl 2000;75:S27-31.
32. Attman PO, Alaupovic P, Samuelsson O: Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease. Kidney Int Suppl 1999;71:S14-17.
33. Schlondorff D: Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 1993;22:72-82.
34. Wasserman J, Santiago A, Rifici V, et al: Interactions of low density lipoprotein with rat mesangial cells. Kidney Int 1989;35:1168-1174.
35. Wheeler DC, Chana RS, Topley N, et al: Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int 1994;45:1628-1636.
36. Nishida Y, Yorioka N, Oda H, et al: Effect of lipoproteins on cultured human mesangial cells. Am J Kidney Dis 1997;29:919-930.
37. Coritsidis G, Rifici V, Gupta S, et al: Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int 1991;39:858-866.
38. Grone EF, Abboud HE, Hohne M, et al: Actions of lipoproteins in cultured human mesangial cells: Modulation by mitogenic vasoconstrictors. Am J Physiol 1992;263:F686-696.
39. Kamanna VS, Pai R, Roh DD, et al: Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation. Lab Invest 1996;74:1067-1079.
40. Kim SY, Guijarro C, O'Donnell MP, et al: Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatin. Kidney Int 1995;48:363-371.
41. Rovin BH, Tan LC: LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 1993;43:218-225.
42. Kim SB, Kang SA, Cho YJ, et al: Effects of low density lipoprotein on type IV collagen production by cultured rat mesangial cells. Nephron 1994;67:327-333.
43. Ding G, Pesek-Diamond I, Diamond JR: Cholesterol, macrophages, and gene expression of TGF-beta 1 and fibronectin during nephrosis. Am J Physiol 1993;264:F577-584.
44. Coimbra TM, Janssen U, Grone HJ, et al: Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000;57:167-182.
45. Ding G, van Goor H, Frye J, et al: Transforming growth factor-beta expression in macrophages during hypercholesterolemic states. Am J Physiol 1994;267:F937-943.
46. Sassy-Prigent C, Heudes D, Mandet C, et al: Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 2000;49:466-475.
47. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20:1-17.
48. Schainuck LI, Striker GE, Cutler RE, et al: Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1970;1:631-641.
49. Striker GE, Schainuck LI, Cutler RE, et al: Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol 1970;1:615-630.
50. Makino H, Sugiyama H, Kashihara N: Apoptosis and extracellular matrix-cell interactions in kidney disease. Kidney Int Suppl 2000;77:S67-75.
51. Gin H, Rigalleau V, Aparicio M: Lipids, protein intake, and diabetic nephropathy. Diabetes Metab 2000;26(suppl 4):45-53.
52. Bonnet F, Cooper ME: Potential influence of lipids in diabetic nephropathy: Insights from experimental data and clinical studies. Diabetes Metab 2000;26:254-264.